Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:24 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2401–2424 of 13,940 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Schizophrenia
Interventions: Xanomeline/Trospium Chloride, Placebo; Drug
Lead sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 472 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 32
States / cities: Bentonville, Arkansas • Little Rock, Arkansas • Rogers, Arkansas + 27 more

Conditions: Quitting Smoking, Smoking Cessation, Smoking, Cigarette
Interventions: Text message smoking treatment, Nicotine replacement therapy sampling, Wisconsin Tobacco QuitLine Referral, Referral to Primary Care Provider, BREATHE 2 Cessation Study, Additional modalities to learn about and request treatment; Behavioral · Drug · Combination Product
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 12,376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Bronchiectasis
Interventions: AZLI, Placebo; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 274 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 33
States / cities: Florence, Alabama • Flagstaff, Arizona • Peoria, Arizona + 30 more

Conditions: Clostridium Difficile Colitis
Interventions: CRS3123, Placebo; Drug · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: ACL, Anterior Cruciate Ligament Injuries
Interventions: Genicular Nerve Block with bupivacaine and preservative free dexamethasone; Drug
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 80 Years
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Burnout, Healthcare Workers, Anxiety, Wellness Program, Depression Not Otherwise Specified
Interventions: Wellness Intervention; Behavioral
Lead sponsor: University of Nevada, Reno; Other
Eligibility: Not listed
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Reno, Nevada

Conditions: Diabetes Mellitus, Type 2
Interventions: Family-DSMES, Standard-DSMES; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 1,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Conditions: Clinical Trial
Interventions: Family Check-Up 4 Health, Treatment as usual; Behavioral · Other
Lead sponsor: Arizona State University; Other
Eligibility: 6 Years to 12 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 3
States / cities: Phoenix, Arizona

Conditions: Malignant Neoplasm
Interventions: Isopropyl Alcohol, Placebo, Questionnaire Administration; Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Fibrillation, Atrial
Interventions: omega-3-acid ethyl esters, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 663 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 178
States / cities: Birmingham, Alabama • Huntsville, Alabama • Anchorage, Alaska + 149 more

Conditions: Pollution; Exposure, Neurodevelopmental Disorders
Interventions: MRI task; Other
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 6 Months to 11 Years
Enrollment: 182 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes, Pre-Diabetes
Interventions: water-soluble cinnamon extract (Cinnulin PF); Drug
Lead sponsor: Mike O'Callaghan Military Hospital; Federal
Eligibility: 18 Years and older
Enrollment: 229 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 4
States / cities: Travis Air Force Base, California • Eglin Air Force Base, Florida • Offutt Air Force Base, Nebraska + 1 more

Conditions: Insomnia, Diabetes Mellitus, Type 2
Interventions: Insomnia Intervention, Information Control; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Laparotomy, Dehiscence Wound, Surgical Site Infections, Trauma Abdomen, Emergency General Surgery
Interventions: triclosan-coated barbed suture, triclosan-coated non-barbed suture, Non-coated non-barbed suture; Device
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 100 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Degenerative Joint Disease of Shoulder
Interventions: Cryoneurolysis, No cryoneurolysis; Device · Other
Lead sponsor: North Texas Medical Research Institute, PLLC; Other
Eligibility: 30 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rockwall, Texas

Conditions: Long COVID, Long Covid19, Long Covid-19
Interventions: Personalized Cardiopulmonary Rehabilitation, Structured Pacing, Education, Usual Care; Behavioral · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 660 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 42
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 33 more

Conditions: Eye Diseases, Visual Impairment, Glaucoma
Interventions: Standard optometric examination, Technology enhanced eye disease detection protocol; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: Intubation, Airway Management
Interventions: CMAC video laryngoscope, Macintosh laryngoscope; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Rectal Hypersensitivity, Irritable Bowel Syndrome-Constipation
Interventions: Sensory Adaptation Training, Escitalopram Therapy; Procedure · Drug
Lead sponsor: Augusta University; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2019
U.S. locations: 2
States / cities: Augusta, Georgia • Iowa City, Iowa

Conditions: Nicotine Dependence, Electronic Cigarette Use, Cigarette Smoking
Interventions: Nicotine, Juul e-cigarette, Reduction; Drug · Device · Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 21 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: GERD Gastroesophageal Reflux Disease
Interventions: Omeprazole, LINX Reflux Management System; Drug · Device
Lead sponsor: Torax Medical Incorporated; Industry
Eligibility: 21 Years and older
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 21
States / cities: Mobile, Alabama • Heber Springs, Arkansas • Los Angeles, California + 18 more

Conditions: Cognitive Impairment, Dementia, Post ICU Syndrome, Critical Illness, Cognitive Impairment, Mild
Interventions: Usual Care post-Intensive Care Unit (ICU), Anticipating Decline and Providing Therapy (ADAPT); Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 60 Years and older
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Cytomegalovirus Infection
Interventions: mRNA-1647, Placebo; Biological
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Boston, Massachusetts • St Louis, Missouri • Seattle, Washington

Conditions: ADHD
Interventions: AR08, Placebo; Drug
Lead sponsor: Arbor Pharmaceuticals, Inc.; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 13
States / cities: Brandenton, Florida • Jacksonville, Florida • North Miami, Florida + 9 more

Search by objective public record fields.

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study

Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis

Phase I Trial of a Single Dose of CRS3123

Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery

The Counselor Led Resident Wellness Study

Comparative Effectiveness of Family DSMES and Standard DSMES Among Diverse Populations

Raising Healthy Children: A Hybrid Trial of the Family Check-Up 4 Health in Primary Care

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation

Air Pollution and Development in the Boricua Youth Study

Cinnamon Trial-lIfestyle iNtervention Plus Water-soluble Cinnamon Extract On loweriNg Blood Glucose in Pre-diabetics

Diabetes Sleep Treatment Trial for Insomnia

Barbed Suture vs Non-Barbed Closure for Emergency Exploratory Laparotomy RCT

Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)

RECOVER-ENERGIZE Platform Protocol

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

Clinical Evaluation of the Storz CMAC Laryngoscope

SAT vs Escitalopram for Rectal Hypersensitivity

E-cigarette Nicotine Study

The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease

Anticipating Decline and Providing Therapy

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

AR08 for Treatment of ADHD in Children